SUVRETTA CAPITAL MANAGEMENT, LLC - Q3 2023 holdings

$1.85 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 87 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 35.0% .

 Value Shares↓ Weighting
RPRX BuyROYALTY PHARMA PLC$111,158,519
+18.7%
4,095,745
+34.4%
6.01%
+19.9%
BuyBIOHAVEN LTD$104,185,656
+12.6%
4,005,600
+3.6%
5.63%
+13.8%
BuyARCELLX INC$102,974,416
+14.3%
2,869,967
+0.8%
5.56%
+15.6%
HZNP SellHORIZON THERAPEUTICS PUB L$90,968,551
+11.5%
786,313
-0.9%
4.92%
+12.7%
INSM BuyINSMED INC$87,019,934
+32.6%
3,446,334
+10.8%
4.70%
+34.0%
FB BuyMETA PLATFORMS INCcl a$84,252,435
+16.9%
280,645
+11.7%
4.55%
+18.1%
AMZN BuyAMAZON COM INC$78,746,899
+84.2%
619,469
+88.9%
4.26%
+86.1%
AMD BuyADVANCED MICRO DEVICES INC$71,615,158
+69.6%
696,510
+87.9%
3.87%
+71.5%
ITCI BuyINTRA-CELLULAR THERAPIES INC$71,355,434
-6.0%
1,369,849
+14.3%
3.86%
-5.0%
MSFT NewMICROSOFT CORP$68,887,178218,170
+100.0%
3.72%
KURA BuyKURA ONCOLOGY INC$66,902,906
-10.0%
7,335,845
+4.4%
3.62%
-9.1%
WYNN BuyWYNN RESORTS LTD$42,513,036
+34.8%
460,048
+54.0%
2.30%
+36.2%
BuyMARINUS PHARMACEUTICALS INC$41,899,783
-4.9%
5,204,942
+28.3%
2.26%
-3.9%
ETNB Buy89BIO INC$41,601,598
-8.3%
2,694,404
+12.6%
2.25%
-7.3%
BuyGENERAL ELECTRIC CO$38,799,623
+83.3%
350,969
+82.1%
2.10%
+85.2%
NVDA BuyNVIDIA CORPORATION$38,517,495
+17.5%
88,548
+14.3%
2.08%
+18.7%
CMG NewCHIPOTLE MEXICAN GRILL INC$37,369,33220,400
+100.0%
2.02%
GPN BuyGLOBAL PMTS INC$32,827,070
+18.5%
284,488
+1.2%
1.77%
+19.8%
TERN BuyTERNS PHARMACEUTICALS INC$30,390,807
-37.6%
6,041,910
+8.6%
1.64%
-36.9%
COGT BuyCOGENT BIOSCIENCES INC$29,769,675
+13.3%
3,053,300
+37.6%
1.61%
+14.5%
LVS SellLAS VEGAS SANDS CORP$29,467,465
-25.9%
642,833
-6.2%
1.59%
-25.1%
EYPT BuyEYEPOINT PHARMACEUTICALS INC$27,902,255
-6.3%
3,492,147
+2.0%
1.51%
-5.3%
ORCL SellORACLE CORP$27,042,541
-28.7%
255,311
-19.8%
1.46%
-28.0%
FULC  FULCRUM THERAPEUTICS INC$25,391,832
+34.5%
5,718,8810.0%1.37%
+36.0%
RARE BuyULTRAGENYX PHARMACEUTICAL IN$24,222,713
-3.0%
679,459
+25.5%
1.31%
-2.0%
KALV BuyKALVISTA PHARMACEUTICALS INC$23,312,795
+27.3%
2,420,851
+19.0%
1.26%
+28.7%
RH SellRH$21,410,252
-21.9%
80,989
-2.6%
1.16%
-21.1%
LLY NewELI LILLY & CO$21,001,78339,100
+100.0%
1.14%
STRO  SUTRO BIOPHARMA INC$20,416,415
-25.4%
5,883,6930.0%1.10%
-24.6%
BCYC NewBICYCLE THERAPEUTICS PLCsponsored ads$20,310,5081,010,976
+100.0%
1.10%
 ZURA BIO LTD$18,810,000
-19.5%
2,850,0000.0%1.02%
-18.7%
BSX BuyBOSTON SCIENTIFIC CORP$18,677,525
+1793.0%
353,741
+1839.3%
1.01%
+1803.8%
BuyPROKIDNEY CORP$17,714,721
-50.4%
3,867,843
+21.1%
0.96%
-49.9%
COF SellCAPITAL ONE FINL CORP$17,630,103
-18.8%
181,660
-8.5%
0.95%
-17.9%
WFC BuyWELLS FARGO CO NEW$17,508,755
-3.1%
428,506
+1.2%
0.95%
-2.1%
NewAPOLLO GLOBAL MGMT INC$17,224,944191,900
+100.0%
0.93%
HLT SellHILTON WORLDWIDE HLDGS INC$17,114,813
+2.4%
113,962
-0.8%
0.92%
+3.5%
IFRX  INFLARX NV$17,087,052
-33.2%
5,733,9100.0%0.92%
-32.5%
MCK BuyMCKESSON CORP$16,324,269
+1987.6%
37,540
+1951.4%
0.88%
+2000.0%
JNJ BuyJOHNSON & JOHNSON$14,032,608
+2.4%
90,097
+8.8%
0.76%
+3.4%
UNH BuyUNITEDHEALTH GROUP INC$13,725,564
+122.7%
27,223
+112.3%
0.74%
+124.8%
SANA BuySANA BIOTECHNOLOGY INC$11,469,534
-9.0%
2,963,704
+40.2%
0.62%
-8.0%
AGIO  AGIOS PHARMACEUTICALS INC$11,236,500
-12.6%
454,0000.0%0.61%
-11.6%
RCUS NewARCUS BIOSCIENCES INC$10,717,927597,099
+100.0%
0.58%
MREO  MEREO BIOPHARMA GROUP PLCspon ads$9,500,125
-2.3%
7,364,4380.0%0.51%
-1.3%
ANAB NewANAPTYSBIO INC$8,610,832479,445
+100.0%
0.46%
KZR  KEZAR LIFE SCIENCES INC$8,529,433
-51.4%
7,167,5910.0%0.46%
-50.9%
SellALVOTECHordinary shares$8,467,026
+9.4%
928,402
-7.2%
0.46%
+10.6%
SNY  SANOFIsponsored adr$6,224,439
-0.5%
116,0410.0%0.34%
+0.6%
ARQT BuyARCUTIS BIOTHERAPEUTICS INC$6,028,055
-27.5%
1,135,227
+30.1%
0.33%
-26.7%
ELAN BuyELANCO ANIMAL HEALTH INC$6,030,260
+37.2%
536,500
+22.8%
0.33%
+38.7%
TEVA NewTEVA PHARMACEUTICAL INDS LTDsponsored ads$5,073,480497,400
+100.0%
0.27%
AZN BuyASTRAZENECA PLCsponsored adr$4,773,583
+85.8%
70,490
+96.4%
0.26%
+88.3%
BNTX  BIONTECH SEsponsored ads$4,450,981
+0.7%
40,9700.0%0.24%
+2.1%
DHR  DANAHER CORPORATION$4,075,539
+3.4%
16,4270.0%0.22%
+4.3%
TMO  THERMO FISHER SCIENTIFIC INC$3,674,794
-3.0%
7,2600.0%0.20%
-2.0%
NewKENVUE INC$3,445,648171,596
+100.0%
0.19%
 PEPGEN INC$2,471,984
-43.2%
486,6110.0%0.13%
-42.5%
NTRA  NATERA INC$2,296,575
-9.1%
51,9000.0%0.12%
-8.1%
ABC  CENCORA INC$2,247,465
-6.5%
12,4880.0%0.12%
-5.5%
NRIX  NURIX THERAPEUTICS INC$2,206,774
-21.3%
280,7600.0%0.12%
-20.7%
INCY  INCYTE CORP$2,172,152
-7.2%
37,6000.0%0.12%
-6.4%
 AKILI INC$2,108,719
-50.5%
3,841,7180.0%0.11%
-50.0%
ABT  ABBOTT LABS$1,997,047
-11.2%
20,6200.0%0.11%
-10.0%
NewAEGLEA BIOTHERAPEUTICS INC$1,989,339162,395
+100.0%
0.11%
PTGX BuyPROTAGONIST THERAPEUTICS INC$1,806,577
-19.4%
108,308
+33.5%
0.10%
-18.3%
GILD  GILEAD SCIENCES INC$1,701,138
-2.8%
22,7000.0%0.09%
-2.1%
MOLN  MOLECULAR PARTNERS AGads$1,656,000
-33.4%
400,0000.0%0.09%
-33.1%
GLPG  GALAPAGOS NVspon adr$1,630,760
-15.0%
47,2000.0%0.09%
-14.6%
IQV  IQVIA HLDGS INC$1,411,681
-12.5%
7,1750.0%0.08%
-11.6%
ARGX SellARGENX SEsponsored adr$1,376,564
+4.2%
2,800
-17.4%
0.07%
+4.2%
MDT  MEDTRONIC PLC$1,368,166
-11.1%
17,4600.0%0.07%
-9.8%
ANTM  ELEVANCE HEALTH INC$1,310,614
-2.0%
3,0100.0%0.07%
-1.4%
ILMN  ILLUMINA INC$1,198,454
-26.8%
8,7300.0%0.06%
-26.1%
CVS  CVS HEALTH CORP$1,198,809
+1.0%
17,1700.0%0.06%
+3.2%
SYK  STRYKER CORPORATION$1,191,457
-10.4%
4,3600.0%0.06%
-9.9%
CI  THE CIGNA GROUP$1,144,280
+1.9%
4,0000.0%0.06%
+3.3%
ISRG  INTUITIVE SURGICAL INC$897,330
-14.5%
3,0700.0%0.05%
-14.3%
WAT  WATERS CORP$863,762
+2.9%
3,1500.0%0.05%
+4.4%
AVTR  AVANTOR INC$806,310
+2.6%
38,2500.0%0.04%
+4.8%
SRPT  SAREPTA THERAPEUTICS INC$734,351
+5.9%
6,0580.0%0.04%
+8.1%
NewBENITEC BIOPHARMA INC$617,092204,220
+100.0%
0.03%
DXCM  DEXCOM INC$548,604
-27.4%
5,8800.0%0.03%
-25.0%
A  AGILENT TECHNOLOGIES INC$557,982
-7.0%
4,9900.0%0.03%
-6.2%
IDXX  IDEXX LABS INC$402,288
-12.9%
9200.0%0.02%
-12.0%
UTHR  UNITED THERAPEUTICS CORP DEL$307,183
+2.3%
1,3600.0%0.02%
+6.2%
 OPY ACQUISITION CORP I*w exp 09/22/202$2,011
-81.5%
72,6050.0%0.00%
-100.0%
TECH ExitBIO-TECHNE CORP$0-2,600
-100.0%
-0.01%
CRL ExitCHARLES RIV LABS INTL INC$0-1,010
-100.0%
-0.01%
MTD ExitMETTLER TOLEDO INTERNATIONAL$0-164
-100.0%
-0.01%
EW ExitEDWARDS LIFESCIENCES CORP$0-2,300
-100.0%
-0.01%
AGLE ExitAEGLEA BIOTHERAPEUTICS INC$0-4,059,894
-100.0%
-0.10%
BNTC ExitBENITEC BIOPHARMA INC$0-769,000
-100.0%
-0.17%
ORIC ExitORIC PHARMACEUTICALS INC$0-492,924
-100.0%
-0.20%
GFL ExitGFL ENVIRONMENTAL INC$0-99,375
-100.0%
-0.21%
ExitCONSTELLATION ENERGY CORP$0-82,592
-100.0%
-0.40%
EVR ExitEVERCORE INCclass a$0-71,051
-100.0%
-0.47%
RETA ExitREATA PHARMACEUTICALS INCcl a$0-108,832
-100.0%
-0.59%
UNP ExitUNION PAC CORP$0-61,152
-100.0%
-0.67%
MRVL ExitMARVELL TECHNOLOGY INC$0-226,873
-100.0%
-0.72%
CELH ExitCELSIUS HLDGS INC$0-96,215
-100.0%
-0.77%
WWE ExitWORLD WRESTLING ENTMT INCcl a$0-150,008
-100.0%
-0.87%
ATVI ExitACTIVISION BLIZZARD INC$0-207,188
-100.0%
-0.93%
PINS ExitPINTEREST INCcl a$0-658,390
-100.0%
-0.96%
DFS ExitDISCOVER FINL SVCS$0-161,056
-100.0%
-1.01%
GS ExitGOLDMAN SACHS GROUP INC$0-63,091
-100.0%
-1.09%
ExitCANADIAN PACIFIC KANSAS CITY$0-259,073
-100.0%
-1.12%
ACN ExitACCENTURE PLC IRELAND$0-70,103
-100.0%
-1.16%
TSM ExitTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$0-237,031
-100.0%
-1.28%
SQ ExitBLOCK INCcl a$0-432,296
-100.0%
-1.54%
KDNY ExitCHINOOK THERAPEUTICS INC$0-1,748,141
-100.0%
-3.59%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ADOBE SYSTEMS INCORPORATED33Q4 202113.2%
CONSTELLATION BRANDS INC20Q4 201810.9%
AMAZON COM INC20Q3 20238.0%
UNITEDHEALTH GROUP INC20Q3 20235.7%
IQVIA HLDGS INC19Q3 20237.3%
RESTAURANT BRANDS INTL INC18Q3 20198.9%
UNION PAC CORP17Q2 20235.1%
META PLATFORMS INC16Q3 202310.9%
COPART INC15Q4 20212.3%
SUTRO BIOPHARMA INC15Q3 20231.9%

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SUVRETTA CAPITAL MANAGEMENT, LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Zura Bio LtdJune 15, 20232,850,0006.6%
InflaRx N.V.April 24, 20235,733,91010.3%
Benitec Biopharma Inc.April 18, 20233,020,21410.0%
Aeglea BioTherapeutics, Inc.February 13, 20236,376,37310.0%
Bolt Biotherapeutics, Inc.Sold outFebruary 13, 202300.0%
Cano Health, Inc.Sold outFebruary 13, 202300.0%
CHIMERIX INCSold outFebruary 13, 202300.0%
Disc Medicine, Inc.Sold outFebruary 13, 202300.0%
OTONOMY, INC.Sold outFebruary 13, 202300.0%
Sio Gene Therapies Inc.Sold outFebruary 13, 202300.0%

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-04-15
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.

Compare quarters

Export SUVRETTA CAPITAL MANAGEMENT, LLC's holdings